1. Experiments were designed to establish the relationship between renal gluconeogenesis and sodium transport. Six inhibitors of gluconeogenesis, with different sites o~action, we!e tested in the isolated perfused rat kidney in which r~nal function, and in particular Na" reabsorption, was followed.
Introduction
The existence of a malate-aspartate shuttle, and its importance in gluconeogenesis, was first established in kidney cortex slices (Rongstad & Correspondence: Dr B. D. Ross, Nuffield Department of Clinical Biochemistry, Radcliffe Infirmary, Oxford, U.K. Katz, 1970) . The malate-aspartate shuttle is the principal means whereby reducing equivalents are transported from mitochondria to cytosol~d its importance extends beyond gluconeog~nesls. to the oxidation of a number of substrates, including glucose and lactate (Meijer & van Dam, 1974) . In the intact functioning kidneythe major energy consuming process is sodium reabsorption from the glomerular filtrate; up to 80% of the normal oxygen consumption is dedicated to this~roce~s (Kramer & Deetjen, 1964) . The relationship between this process and gluconeogenesis has not been clearly established. Gluconeogenesis too requires energy and may under specified circumstances compete with Na" transport for available ATP (Silva, Ross & Spokes, 1980) .
The malate-aspartate shuttle offers a possible metabolic link between sodium reabsorption and gluconeogenesis by controlling the provision of ATP from specified substrates, oxidation of which supports active sodium transport.
The present study was undertaken to examine the relationship between gluconeogenesis and sodium transport in the kidney, and in particular to determine whether the malate-aspartate shuttle is required for optimum Na" transport. The term 'gluconeogenesis' is used to cover the whole sequence of enzymes, metabolic intermediates and energy consuming reactions anyone of which may be able to regulate another metabolic event. The isolated perfused kidney was used for this study since it has already been established that glucose oxidation supports sodium transport in this preparation (Frega, Weinberg, Ross & Leaf, 1977; Ross, 1978) , and both metabolism and sodium transport can readily be measured.
By using a variety of metabolic inhibitors, and individual metabolic substrates, it is shown that the malate-aspartate shuttle is important for optimum sodium transport in the fed and starved rat kidney.
Methods

Experimental animals
Male rats, weighing 30~00 g, were used in all experiments. Animals were allowed free access to food and water until the day of the experiment or fasted for 24 h to obtain increased rates of gluconeogenesis.
Isolated rat kidney perfusions
Perfusion of the right kidney was performed by the technique as described by Nishiitsutsuji-Uwo, Ross & Krebs (1967) as modified by Ross, Epstein & Leaf (1973) . The animals were anaesthetized with pentobarbital intraperitoneally (60 mg/kg), Heparin (1000 units) was injected into the femoral vein. The peritoneal cavity was opened and a PE catheter placed in the right ureter. A glass arterial cannula was inserted into the superior mesenteric artery and threaded across the aorta into the right renal artery. Perfusion was started while the cannula was still in the mesenteric artery, avoiding thereby any ischaemia to the kidney. The kidney was then placed in a constant temperature cabinet at 37°C. Perfusion medium was recirculated continuously with pulsatile flow at a pressure of 110/90 mmHg. Rate of flow of the perfusate was measured with an in-line Brooks flowmeter, installed in series in the arterial line. Perfusion medium consisted of a Krebs-RingerHenseleit solution containing (in mmol/I) sodium 143, chloride 103, potassium 4·5, bicarbonate 25, calcium 2·5, magnesium 1·2, phosphate 1·2 at a pH of 7·4 when gassed with a mixture of 02 + CO 2 (95 :5, v/v) , and bovine serum albumin at a concentration of 67 g/l.
Glucose was measured in both perfusate and urine by using hexokinase. The results are expressed in ,umol of glucose generated h-1 g-l dry weight of kidney. The rate of production of glucose was calculated from the rate of change in the total amount of glucose in the recirculating medium. The total amount of glucose in the recirculating medium at the end of each clearance period was calculated from the volume of perfusate and the concentration of glucose at every collection period. Volume of perfusate for every period was calculated back from the final measured volume, the sampling volume, the urine volume and the evaporative loss of water. Due allowances were made for the amount of glucose lost when the recirculating perfusate was sampled and for that lost in the urine (the latter was negligible).
Metabolic inhibitors
Unless otherwise indicated, metabolic inhibitors were added to the perfusion medium as a solution in a small volume (0·5 ml) of KrebsHenseleit saline after 30-40 min of perfusion, during which control rates of metabolism were determined. Perfusion was continued for a further 30 min in the presence of the metabolic inhibitor. 3-Mercaptopicolinate (final concn. in perfusion medium 0·15 mmol/I) was dissolved immediately before use. Amino-oxyacetate (1 mmol/I), D-malate (2 mmol/I), dichloroacetate (1 mmol/I) and quinolinate (2 mmol/I) were added as their sodium salt from a stock solution (0· I mol/I). Ouabain (Sigma Chemical Co.) was dissolved in I ml of boiling distilled water immediately before addition to the perfusion medium at a final concentration of 50 mmol/l.
Determination ofmetabolites
After 60 min of perfusion kidneys were freeze-clamped while perfusion continued and extracts prepared in perchloric acid as previously described (Nishiitsutsuji-Uwo et al., 1967) . The following metabolites were determined in the neutralized extracts: ATP (Lamprecht & Trautschold, 1974) ; glucose (Bergmeyer, Bernt, Schmidt & Stork, 1974) ; lactate (Gutmann & Wahlefeld, 1974a) ; pyru vate, phosphoenolpyruvate, 2-phosphoglycerate (Czok & Lamprecht, 1974) ; 3-phosphoglycerate (Czok, 1974) ; 2-oxoglutarate ; citrate (Mollering & Gruber, 1966) ; malate (Gutmann & Wahlefeld, 1974b) ; aspartate (Bergmeyer, Bernt, Mollering & Pfleiderer. 1974) ; oxaloacetate was determined by using malic dehydrogenase (Wahlefeld, 1974) with an Aminco double-beam spectrophotometer in extracts within a few minutes of their preparation. Glucose and lactate were also determined in the perfusion medium.
Calculation ofresults
Inulin clearance and sodium reabsorption were calculated as described earlier (Ross et al., 1973) . For each 30 min period, three clearance periods were used for glomerular filtration rate (GFR) and sodium reabsorption and the mean value before and after addition of the inhibitor was calculated. Experiments in which, for technical reasons, urine flow was not established in the first 20 min were discarded. Total sodium transport was calculated from GFR and fractional sodium excretion and expressed as ,umol min" s' of kidney. Both clearance data and metabolic rates were compared for the control and experimental periods of perfusion, by Student's paired r-test, Tissue content of metabolites was expressed as ,umol/g dry weight to eliminate variation due to increase in the wet/dry weight ratio of kidneys after perfusion. The wet/dry ratio for perfused kidney = 4·56 ± 0·10 (20 kidneys), for perfused kidney, freeze-clamped = 5·20 ± 0·20 (20) and for control kidneys, not perfused = 3·46 ± 0·12 (20).
Results
In order to separate the effects of inhibiting the malate-aspartate shuttle from the concurrent inhibition of gluconeogenesis, the effects of a variety of metabolic inhibitors with different sites of action on the gluconeogenic pathway were tested.
Rats were fasted for 24 h to increase the maximum rate of gluconeogenesis and the kidney was perfused with medium containing either sodium t-lactate (5 or 10 mmol/l), sodium pyruvate (5 mmol/l) or D-fructose (10 mmol/l). The rates of glucose synthesis determined over 60 min were similar to those reported earlier (Nishiitsutsuji-Uwo et al., 1967) (Table 1) . Sodium quinolinate, amino-oxyacetate and 3-mercaptopicolinate inhibited glucose synthesis from L-lactate by 90% or more in each case. Dichloroacetate inhibited glucose synthesis by only 40%, whereas ouabain, which in isolated cortical tubules may actually stimulate glucose synthesis from lactate (Freidrichs & Schoner, 1973) , inhibited glucose synthesis by 40% in the perfused kidney. 0-Malate inhibited glucose synthesis from pyruvate by 70 or 80% as expected but was without effect when L-lactate was the substrate. Unxpectedly, D-malate inhibited glucose synthesis from n-fructose almost entirely. Neither of the main pathways described for conversion of fructose into glucose (Krebs & Lund, 1966) involves malic dehydrogenase, so that D-malate is less specific in its actions than previously considered (Rongstad & Katz, 1970) .
In keeping with its site of action on the transaminase step of the malate-aspartate shuttle (see the Discussion section) amino-oxyacetate was without effect on glucose formation from pyruvate.
As previously reported (Ross, 1976) , t-tryptophan, a potent inhibitor of hepatic gluconeogenesis, was without effect in the perfused kidney (results not shown in detail). This is consistent with the absence of tryptophan pyrrolase in rat kidney (B. Ross, P. Silva & S. Bullock, unpublished work).
Effect ofamino-oxyacetate on renal metabolism
The metabolic effects of amino-oxyacetate observed in the perfused kidney were consistent with the inhibition of the malate-aspartate shuttle described for this compound in kidney cortex TABLE 1. Effect ofinhibitors on glucose synthesis in the perfused rat kidney Kidneys of rats fasted for 24 h were perfused with substrates at a concentration of 5 or 10 mmol/l for 60 min, and in the presence of one of the metabolic inhibitors indicated. The rate of glucose synthesis was calculated from samples of medium taken at 15 min intervals, and were linear for the duration of the experi- slices and in liver cells (Rongstad & Katz, 1970) . When glucose (5 mmol/l) was the substrate lactate production was increased in the presence of amino-oxyacetate from 49 ± 4· 7 (no. of experiments 7) to 105 ± 5·0 (8) .umol h-I g-I dry weight without any measurable change in the rate of glucose uptake (Table 2) . It is probable, therefore, that in the presence of amino-oxyacetate total oxidation of glucose was reduced. When lactate (5 mmol/l) was the sole substrate amino-oxyacetate inhibited glucose formation (Table 1) , but the rate of removal of lactate was reduced to a greater extent than expected from the inhibition of gluconeogenesis alone (-461 ,LImol instead of -116 .umol/g dry wt.). This indicated an additional inhibition of lactate oxidation by amino-oxyacetate. Notably, lactate production from pyruvate continued at the control rate, suggesting that in perfused kidney, as in isolated liver cells (Meijer & van Dam, 1974) , a shuttle exists, apart from the malate-aspartate shuttle, for the transfer of reducing equivalents (NADH) out of, but not into mitochondria. Fig. 1 shows that amino-oxyacetate (1 mmol/l) and D-malate (2 mmol/l) were the only inhibitors of glucose synthesis that had a consistent inhibitory effect on sodium reabsorption in the perfused kidney. Amino-oxyacetate (1 mmol/l) reduced absolute sodium reabsorption by 30% when lactate (10 mmol/l) was the substrate, by 18% when D-glucose (5 mmol/l) was the substrate, but had no effect when pyruvate (10 mmol/l) was the substrate. D-Malate inhibited sodium reabsorption by 60% only when pyruvate (10 mmol/l) was the substrate. These results parallel the effects of amino-oxyacetate and D-malate on glucose synthesis from these substrates. Dichloroacetate (1 mmol/l) had no inhibitory effect on sodium reabsorption in the presence of either lactate or glucose. 3-Mercaptopicolinate, at concentrations which fully inhibit gluconeogenesis, had no effect on either total or fractional sodium reabsorption when either lactate (10 mmol/l), pyruvate (10 mmol/l), glucose (5 mmol/l) or glutamine (1 or 5 mmol/l; not shown) was used as substrate.
Effect of various inhibitors of glucose synthesis on sodium transport
Discussion
Site of action of principal inhibitors of glucose synthesis in the perfused kidney
With the exception of quinolinate, which has been reported to inhibit glutamate dehydrogenase (Schoolwerth & Klahr, 1972) and was not further explored in this study, the site of action of each of the inhibitors on gluconeogenesis is known (Fig. 2) .
Mercaptopicolinate inhibits at phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32). Dichloroacetate activates pyruvate dehydrogenase and lowers tissue pyruvate content, but its effect on gluconeogenesis in the perfused kidney could involve another site of action (Lacey & Randle, 1978) . Amino-oxyacetate, an inhibitor of glutamic-oxaloacetic transaminase (EC 2.6.1.1) inhibits gluconeogenesis from lactate by inhibiting the mitochondrial transfer of reducing equivalents, via the malate-aspartate shuttle. n-Malate, an inhibitor of L-malic dehydrogenase (EC 1.1.1.37), also inhibits the malate-aspartate shuttle (Rongstad & Katz, 1970) but at a different point, and hence inhibits glucose formation from pyruvate but not from lactate. D-Malate may have another hitherto undescribed effect, since glucose synthesis from fructose, a process which is independent of the malateaspartate shuttle, was inhibited significantly by D-malate at 2 or 10 mmol/l. It is therefore difficult to interpret the effects of D-malate on Na+ transport. 
Role of malate-aspartate shuttle in Na" reabsorption
The present experiments demonstrate the necessity of the malate-aspartate shuttle for optimum sodium transport. This was first proposed by Schurek, Brecht, Lohfert & Hierholzer (1975) to explain a stimulatory effect of gluta-FIG. 1. Effect of 3-mercaptopicolinate (0·15 rnmol/l), amino-oxyacetate (1 mmol/l), D-malate (2 and 10 mmol/l), dichloroacetate (1 mmol/l) and ouabain (0· 1 mmol/l) in isolated rat kidneys perfused with (a) lactate (10 mmol/l), (b) pyruvate (10 mmol/l), or (c) glucose (5 mmol/l) as the sole exogenous substrates. The vertical axis represents the change in the rate of sodium reabsorption (TN.) after the addition of the inhibitors and it is expressed as a percentage of the average total sodium reabsorption for the control periods. This number is given on the right side of each ordinate. TN. is defined as total sodium reabsorbed in unit time and is calculated from the relationship [filtered load of sodium (GFR x plasma sodium) -excretedNa" (urinevolume x urine sodium)].Numbers of experiments are givenin parentheses. mate and oxaloacetate on Na" transport. Aminooxyacetate inhibited the oxidation of both lactate and glucose to a considerable extent, whereas oxidation of pyruvate was unaffected. It has been repeatedly demonstrated (Schurek et al., 1975; Ross et al., 1973; Trimble & Bowman, 1973 )that in the isolated perfused kidney optimum sodium transport is achieved only in the presence of specified oxidizable substrates, which presumably supply ATP for active transport. In heart muscle (Safer, Smith & Williamson, 1971) and in isolated liver cells (Ylikahri, Hassinen & Kahonen, 1971 ) the maximum rate of glucose oxidation can be inhibited by inhibitors of the malate-aspartate shuttle. This is the most probable mechanism whereby amino-oxyacetate inhibited sodium transport in the kidney, since this compound had no effect on sodium reabsorption when added in the presence of pyruvate; pyruvate is oxidized independently of the malate-aspartate shuttle.
An unanswered question concerns the anatomical site(s) of inhibition of Na" transport and substrate oxidation by arnino-oxyacetate. This is complicated by the heterogeneity of tissues present in the intact kidney. The inhibitory effect on gluconeogenesis is of necessity localized to cortex. Lactate oxidation also occurs in cortex (Krebs, Bennett, de Gasquet, Gascoyne & Yoshides, 1963) . Oxidation of glucose is a minor process in kidney cortex, but both glucose and lactate are readily oxidized in outer medulla (Lee, Vance & Cahill, 1962 ). An important part of the active Na" transport of kidney is located in the thick ascending limb of Henle's loop in the outer medulla. The major effect of glucose on Nat transport may therefore be in outer medulla (Ross et al., 1973) . It is likely that the inhibitory effect of amino-oxyacetate and hence the relevant activity of the malate-aspartate shuttle is in outer medulla rather than cortex. If this is the case, then ATP 'spared' by the concomitant inhibition of cortical gluconeogenesis is not available to maintain Na" reabsorption by virtue of spatial separation within the kidney.
Significance ofgluconeogenesis in renalfunction
There is no suggestion from the present studies that gluconeogenesis itself is required for active transport of sodium. Glucose formed by renal gluconeogenesis alone is unable to support active sodium reabsorption (Frega et al., 1977, and present study) . In whole kidney there is no evidence of direct competition between gluconeogenesis and sodium transport, as has been suggested by earlier studies in tissue slices (Fulgraff, Nunemann & Sudhoff, 1972) . Thus Freidrichs & Schoner (1973) , Guder & GruberStukowski (1977) and McGeogh, FalconerSmith, Ledingham & Ross (1978) have all observed stimulation of glucose synthesis from lactate by ouabain, an inhibitor of active Na" transport. Fulgraff et al. (1972) attributed a similar stimulation of gluconeogenesis in kidney cortex slices by some diuretic drugs to the sparing of ATP which may follow inhibition of Na" transport. However, the extent to which net sodium transport occurs in these fragmented tissue preparations is uncertain and these experiments are open to alternative interpretation (Guder & Gruber-Stukowski, 1977) . In the perfused kidney ouabain consistently inhibited glucose synthesis from lactate (Table 1) .
These findings in normal rat kidney are in apparent contrast to earlier reports (Silva, Ross & Epstein, 1976; Silva et al. 1980) which suggest a competitive relationship between gluconeogenesis and sodium reabsorption. This was found in kidneys from steroid treated rats in which the rate of gluconeogenesis was increased threefold, It appears probable that at normal rates of gluconeogenesis and of sodium transport the rates of substrate oxidation and ATP supply are sufficientto cover the demands of both processes for energy without apparent competition.
As suggested by the present results, gluconeogenesis and sodium transport may be linked in more subtle ways. Fig. 3 attempts to summarize the present state of information concerning the possible role of gluconeogenesis in renal function. The best established is its importance as a pathway for the disposal of the carbon-chain of glutamine in the regulation of ammoniagenesis (Goodman, Fuisz & Cahill, 1966; Ross & Tannen, 1979) . Glutamine reabsorption (entry into the proximal tubular cell from the luminal pole) is not dependent on gluconeogenesis (Ross, Silva & Bullock, 1977; Silbernagl, 1980) . However, the luminal transport of another important gluconeogenic precursor, lactate, is strongly inhibited by inhibitor(s) of glucose synthesis (Baumann, Frohnert, Hohmann & Kinne, 1972 ; B, Ross, P. Silva & S. Bullock, unpublished work).
The most likely explanation for the failure to observe more profound interdependence of two of the most important energy-consuming processes in the kidney is the existence of cellular heterogeneity which results in the spatial separation of gluconeogenesisand sodium transport.
